Cell Surface Markers Market hits at CAGR of 8.1% by 2023Posted by Kriti on July 15th, 2019 The cell surface markers market is valued at an estimated USD 520 million in 2018 and is projected to reach USD 769 million by 2023, at a CAGR of 8.1% during the forecast period. The Research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Cell Surface Markers Market, along with revenue estimates & forecasts and market share analysis. The growth of this market is driven by factors such as the high global prevalence of cancer, growth in stem cell and neurobiology research, and the increasing funding for life sciences research. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=216278622 Cell Surface Markers Market segmentation:
The Major Players Opearting in the Cell Surface Markers Market: Key players in the Cell Surface Markers Market include Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), Becton, Dickinson and Company (US), F. Hoffman-La Roche (Switzerland), Bio-Rad Laboratories (US), Danaher Corporation (US), Abcam (UK), GenScript (China), BioLegend (US), Cell Signaling Technology (US), Merck KGaA (Germany), and Bio-Techne (US). Thermo Fisher Scientific was the leading player in the global Cell Surface Markers Market. The company has a strong presence in North America, Europe, Asia, and Latin America. It adopts organic and inorganic growth strategies such as acquisitions and expansions. For instance, in the last three years, the company acquired Affymetrix (US) and the Advanced Bioprocessing business from Becton, Dickinson and Company (US). Such acquisitions help Thermo Fisher in strengthening its Life Sciences Solutions segment for versatile product offerings. The company’s efforts towards enhancing its financial strategies have also significantly helped in sustaining its existing position within this market. Geographical Detailed Analysis for Cell Surface Markers Market: North America is the largest regional segment in the Cell Surface Markers Market followed by Europe, Asia, and the Rest of the World (Row). Growth in the North American market is primarily driven by the increasing number of R&D activities and the growing use of cell surface markers in personalized medicine and drug discovery & development. Read More in Detailed (Cell Surface Markers): https://www.marketsandmarkets.com/PressReleases/cell-surface-markers.asp
Mr. Shelly Singh MarketsandMarkets™ INC. 630 Dundee Road Suite 430 Northbrook, IL 60062 USA: 1-888-600-6441 Email: sales@marketsandmarkets.com Like it? Share it! More by this author |
